Evidence map›Paper›PMID 41959120›Full record

ArticlebioRxiv : the preprint server for biology2026

Hybrid crosses reveal a cell-type-specific landscape of mouse regulatory variation.

Ryan Weber, Maria Carilli, Elisabeth Rebboah, Gohassan Filimban, Heidi Yahan Liang, Diane Trout, Margaret Duffield, Parvin Mahdipoor, Erisa Taghizadeh, Negar Fattahi and 10 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ryan WeberDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0003-2044-9297
Maria CarilliDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0002-8977-7224
Elisabeth RebboahDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0003-2273-0189
Gohassan FilimbanDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0002-2612-2554
Heidi Yahan LiangDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0002-6190-9723
Diane TroutDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0002-4928-5532
Margaret DuffieldDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0009-1860-7269
Parvin MahdipoorDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0002-3377-8583
Erisa TaghizadehDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0001-6677-9921
Negar FattahiDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0001-9222-0793
Negar MojganiDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0000-1846-2332
Romina MojaverzargarDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0009-0004-9176-2154
Nikhila SwarnaDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.
Shimako KawauchiTransgenic Mouse Facility, University of California Irvine, Irvine, USA.ORCID 0000-0002-8577-4763
Brian A WilliamsDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0003-3253-611X
Grant R MacGregorDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0001-7598-9501
Barbara J WoldDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0003-3235-8130
Lior PachterDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0002-9164-6231
Ingileif B HallgrimsdottirDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA.ORCID 0000-0002-4710-0047
Ali MortazaviDevelopmental and Cell Biology, University of California Irvine, Irvine, USA.ORCID 0000-0002-4259-6362

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Center for Mouse Genomic Variation at Single Cell ResolutionUM1HG012077 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Seyed Ali Mortazavi, BARBARA J WOLD · 2021 to 2026
$13.7M
NCI NIH HHS P30 CA062203NHGRI NIH HHS UM1 HG012077
6 · The paper itself

Abstract

Understanding the genetic architecture of gene expression is fundamental to evolutionary biology and medicine. As part of the IGVF Consortium, we present a single-nucleus RNA-seq resource of 5.3 million nuclei across eight tissue groups, featuring seven F1 hybrids from C57BL/6J dams crossed with the other Collaborative Cross founder strains for comparison against parental strains. We identify 25,864 genes (91% of those detected) exhibiting non-conserved regulatory behavior in at least one of 92 cell types in one or more crosses. Our results show that while cis-acting variation primarily drives divergence, trans-acting effects are substantially more cell-type specific and sensitive to tissue environment. Notably, bulk tissue analyses frequently mask these signals, particularly in smaller populations such as astrocytes. Furthermore, increasing genetic divergence primarily expands the landscape of cis-acting variation, while trans-acting effects remain stable across genetic distances within species. This atlas establishes a foundational framework for decoding the complex interplay between genetic variation and cell-type-specific regulation across the mammalian body.

Identifiers

PMID41959120
PMCPMC13060228

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.